We are live on ! Find out more
ARTL icon

Artelo Biosciences
ARTL

1 hedge funds and large institutions have $15K invested in Artelo Biosciences in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% more ownership

Funds ownership: 0.42% → 0.44% (+0.02%)

0% more funds holding

Funds holding: 1 → 1 (0)

61% less capital invested

Capital invested by funds: $38K → $15K (-$23K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ARTL Hedge Fund Activity: Q1 2020 in Review

1 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q1 2020, worth a combined $15K — down 61% from $38K a quarter earlier.

Fund positioning in ARTL was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Artelo Biosciences (ARTL) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $15K of Artelo Biosciences stock for Q1 2020, down 61% quarter-over-quarter.
  • 0 funds opened new Artelo Biosciences positions in Q1 2020 and 0 closed out.

Based on aggregated 13F filings for Q1 2020.